|
|
|
|
|
|
|
||
The Journal of General Physiology, Vol 101, 629-650, Copyright © 1993 by The Rockefeller University Press
ARTICLES |
TC Hwang, M Horie and DC Gadsby
Laboratory of Cardiac/Membrane Physiology, Rockefeller University, New York 10021.
The regulation of cardiac Cl- conductance by cAMP-dependent protein kinase (PKA) and cellular phosphatases was studied in isolated guinea pig ventricular myocytes by using wide-tipped, perfused pipettes to record whole-cell currents. Exposure to forskolin (Fsk) or isoproterenol (Iso) elicits a Cl- conductance that results exclusively from PKA-dependent phosphorylation because it can be completely abolished, or its activation fully prevented, by switching to pipette solution containing PKI, a synthetic peptide inhibitor of PKA. The Cl- conductance activated by micromolar concentrations of either agonist reached its steady-state amplitude in 1-2 min and was deactivated promptly and entirely, usually within 2 min, upon washing out the agonist, implying a continuous high level of activity of endogenous protein phosphatases. Accordingly, intracellular application of okadaic acid or microcystin, both potent inhibitors of protein phosphatases 1 and 2A, during exposure to Fsk enhanced the steady-state Cl- conductance and slowed its deactivation after washing out the Fsk. Maximal potentiation of the conductance, by approximately 60%, was obtained with pipette concentrations of approximately 10 microM okadaic acid (or approximately 5 microM microcystin) and did not result from an increase in the apparent affinity for Fsk. In the presence of maximally effective concentrations of okadaic acid and/or microcystin, deactivation of the enhanced Cl- conductance upon washout of agonist was incomplete, with about half of the conductance persisting indefinitely. That residual conductance did not reflect continued action of PKA because it was insensitive to PKI, but was identified as a fraction of the activated Cl- conductance by its biophysical characteristics. The results suggest that complete deactivation of the PKA-regulated cardiac Cl- conductance requires dephosphorylation by a type 1 and/or 2A phosphatase, but that partial deactivation can be accomplished by activity of some other phosphatase(s). These findings are consistent with sequential phosphorylation of a protein, probably the Cl- channel itself, at two different kinds of sites. The resulting phosphoproteins can be distinguished on the basis of their different contributions to whole-cell Cl- conductance.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Chassin, M. W. Hornef, M. Bens, M. Lotz, J.-M. Goujon, S. Vimont, G. Arlet, A. Hertig, E. Rondeau, and A. Vandewalle Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin J. Exp. Med., November 26, 2007; 204(12): 2837 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Artigas, S. J. Al'Aref, E. A. Hobart, L. F. Diaz, M. Sakaguchi, S. Straw, and O. S. Andersen 2,3-Butanedione Monoxime Affects Cystic Fibrosis Transmembrane Conductance Regulator Channel Function through Phosphorylation-Dependent and Phosphorylation-Independent Mechanisms: The Role of Bilayer Material Properties Mol. Pharmacol., December 1, 2006; 70(6): 2015 - 2026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Thelin, M. Kesimer, R. Tarran, S. M. Kreda, B. R. Grubb, J. K. Sheehan, M. J. Stutts, and S. L. Milgram The Cystic Fibrosis Transmembrane Conductance Regulator Is Regulated by a Direct Interaction with the Protein Phosphatase 2A J. Biol. Chem., December 16, 2005; 280(50): 41512 - 41520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Bompadre, T. Ai, J. H. Cho, X. Wang, Y. Sohma, M. Li, and T.-C. Hwang CFTR Gating I: Characterization of the ATP-dependent Gating of a Phosphorylation-independent CFTR Channel ({Delta}R-CFTR) J. Gen. Physiol., March 28, 2005; 125(4): 361 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang and K. D. Gillis A Highly Ca2+-sensitive Pool of Granules Is Regulated by Glucose and Protein Kinases in Insulin-secreting INS-1 Cells J. Gen. Physiol., November 29, 2004; 124(6): 641 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Dousmanis, A. C. Nairn, and D. C. Gadsby Distinct Mg2+-dependent Steps Rate Limit Opening and Closing of a Single CFTR Cl- Channel J. Gen. Physiol., May 28, 2002; 119(6): 545 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Luo, T. Zhu, A. Evagelidis, M. D. Pato, and J. W. Hanrahan Role of protein phosphatases in the activation of CFTR (ABCC7) by genistein and bromotetramisole Am J Physiol Cell Physiol, July 1, 2000; 279(1): C108 - C119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Akabas Cystic Fibrosis Transmembrane Conductance Regulator. STRUCTURE AND FUNCTION OF AN EPITHELIAL CHLORIDE CHANNEL J. Biol. Chem., February 11, 2000; 275(6): 3729 - 3732. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz Anion Transport in Heart Physiol Rev, January 1, 2000; 80(1): 31 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Herzig and J. Neumann Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes Physiol Rev, January 1, 2000; 80(1): 173 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zhu, D. Dahan, A. Evagelidis, S.-X. Zheng, J. Luo, and J. W. Hanrahan Association of Cystic Fibrosis Transmembrane Conductance Regulator and Protein Phosphatase 2C J. Biol. Chem., October 8, 1999; 274(41): 29102 - 29107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Becq, Y. Mettey, M. A. Gray, L. J. V. Galietta, R. L. Dormer, M. Merten, T. Metaye, V. Chappe, C. Marvingt-Mounir, O. Zegarra-Moran, et al. Development of Substituted Benzo[c]quinolizinium Compounds as Novel Activators of the Cystic Fibrosis Chloride Channel J. Biol. Chem., September 24, 1999; 274(39): 27415 - 27425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sorota Insights into the structure, distribution and function of the cardiac chloride channels Cardiovasc Res, May 1, 1999; 42(2): 361 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. SHEPPARD and M. J. WELSH Structure and Function of the CFTR Chloride Channel Physiol Rev, January 1, 1999; 79(1): 23 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. GADSBY and A. C. NAIRN Control of CFTR Channel Gating by Phosphorylation and Nucleotide Hydrolysis Physiol Rev, January 1, 1999; 79(1): 77 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. He, S. Raman, Y. Guo, and W. W. Reenstra Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms Am J Physiol Cell Physiol, October 1, 1998; 275(4): C958 - C966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Yurko-Mauro and W. W. Reenstra Prostaglandin F2alpha stimulates CFTR activity by PKA- and PKC-dependent phosphorylation Am J Physiol Cell Physiol, September 1, 1998; 275(3): C653 - C660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Hool, L. M. Middleton, and R. D. Harvey Genistein Increases the Sensitivity of Cardiac Ion Channels to ß-Adrenergic Receptor Stimulation Circ. Res., July 13, 1998; 83(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T Rapundalo Cardiac protein phosphorylation: functional and pathophysiological correlates Cardiovasc Res, June 1, 1998; 38(3): 559 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Luo, M. D. Pato, J. R. Riordan, and J. W. Hanrahan Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1397 - C1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Smith, S. J. Delaney, J. R. Dorin, R. Farley, D. M. Geddes, D. J. Porteous, B. J. Wainwright, and E. W. F. W. Alton Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice Am J Physiol Cell Physiol, February 1, 1998; 274(2): C492 - C499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pelzer, Y. You, Y. M. Shuba, and D. J. Pelzer beta -Adrenoceptor-coupled Gs protein facilitates the activation of cAMP-dependent cardiac Cl- current Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2539 - H2548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Cotten and M. J. Welsh Covalent Modification of the Regulatory Domain Irreversibly Stimulates Cystic Fibrosis Transmembrane Conductance Regulator J. Biol. Chem., October 10, 1997; 272(41): 25617 - 25622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hirayama and H. C. Hartzell Effects of Protein Phosphatase and Kinase Inhibitors on Ca2+ and Cl- Currents in Guinea Pig Ventricular Myocytes Mol. Pharmacol., October 1, 1997; 52(4): 725 - 734. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. M. Travis, H. A. Berger, and M. J. Welsh Protein phosphatase 2C dephosphorylates and inactivates cystic fibrosis transmembrane conductance regulator PNAS, September 30, 1997; 94(20): 11055 - 11060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-S. Zhou, A. Takai, M. Tominaga, and Y. Okada Phosphatase-Mediated Enhancement of Cardiac cAMP-Activated Cl- Conductance by a Cl- Channel Blocker, Anthracene-9-Carboxylate Circ. Res., August 19, 1997; 81(2): 219 - 228. [Abstract] [Full Text]
|
|
|
|
|
|
F. Becq, B. Verrier, X.-B. Chang, J. R. Riordan, and J. W. Hanrahan cAMP- and Ca2+-independent Activation of Cystic Fibrosis Transmembrane Conductance Regulator Channels by Phenylimidazothiazole Drugs J. Biol. Chem., July 5, 1996; 271(27): 16171 - 16179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tominaga, M. Horie, S. Sasayama, and Y. Okada Glibenclamide, an ATP-Sensitive K+ Channel Blocker, Inhibits Cardiac cAMP-Activated Cl- Conductance Circ. Res., August 1, 1995; 77(2): 417 - 423. [Abstract] [Full Text]
|
|
|
|
